{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:19:31Z","timestamp":1785158371330,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM103427"],"award-info":[{"award-number":["P20GM103427"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI116723"],"award-info":[{"award-number":["AI116723"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.parint.2017.10.010","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T06:00:29Z","timestamp":1515045629000},"page":"107-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Novel Toxoplasma gondii inhibitor chemotypes"],"prefix":"10.1016","volume":"67","author":[{"given":"A.G.","family":"Sanford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.T.","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.P.","family":"Potluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Hemsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Zach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Charman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Vennerstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.H.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parint.2017.10.010_bb0005","doi-asserted-by":"crossref","first-page":"e90203","DOI":"10.1371\/journal.pone.0090203","article-title":"Toxoplasmosis\u2013a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries","volume":"9","author":"Flegr","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.parint.2017.10.010_bb0010","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/605433","article-title":"Risk factors for Toxoplasma gondii infection in the United States","volume":"49","author":"Jones","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.parint.2017.10.010_bb0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7150\/jgen.18378","article-title":"Detection of intestinal pathogens in river, shore, and drinking water in lima, Peru","volume":"5","author":"Grothen","year":"2017","journal-title":"J. Genomics"},{"key":"10.1016\/j.parint.2017.10.010_bb0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis: a history of clinical observations","volume":"39","author":"Weiss","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.parint.2017.10.010_bb0025","doi-asserted-by":"crossref","first-page":"589295","DOI":"10.1155\/2012\/589295","article-title":"Toxoplasma on the brain: understanding host-pathogen interactions in chronic CNS infection","volume":"2012","author":"Kamerkar","year":"2012","journal-title":"J. Parasitol. Res."},{"key":"10.1016\/j.parint.2017.10.010_bb0030","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0149-2918(96)80059-2","article-title":"Treatment regimens for patients with toxoplasmic encephalitis","volume":"18","author":"Fung","year":"1996","journal-title":"Clin. Ther."},{"key":"10.1016\/j.parint.2017.10.010_bb0035","series-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","article-title":"Toxoplasma gondii","author":"Montoya","year":"2015"},{"key":"10.1016\/j.parint.2017.10.010_bb0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0002-9343(89)90378-1","article-title":"Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome","volume":"86","author":"Cohn","year":"1989","journal-title":"Am. J. Med."},{"key":"10.1016\/j.parint.2017.10.010_bb0045","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/AAC.02009-15","article-title":"Clinically available medicines demonstrating anti-toxoplasma activity","volume":"59","author":"Neville","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2017.10.010_bb0050","first-page":"AAC-01176","article-title":"A review of experimental compounds demonstrating anti-toxoplasma activity","author":"McFarland","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2017.10.010_bb0055","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrd2132","article-title":"Drugs, their targets and the nature and number of drug targets","volume":"5","author":"Imming","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.parint.2017.10.010_bb0060","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature09099","article-title":"Chemical genetics of Plasmodium falciparum","volume":"465","author":"Guiguemde","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.parint.2017.10.010_bb0065","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/1099-1085(200011\/12)14:16\/17<3183::AID-HYP404>3.0.CO;2-K","article-title":"On the future of distributed modelling in hydrology","volume":"14","author":"Beven","year":"2000","journal-title":"Hydrol. Process."},{"key":"10.1016\/j.parint.2017.10.010_bb0070","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1021\/jm0100990","article-title":"ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds","volume":"19","author":"Lombardo","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.parint.2017.10.010_bb0075","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/jps.10494","article-title":"Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol\/water and immobilized artificial membrane lipophilicity","volume":"92","author":"Valko","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.parint.2017.10.010_bb0080","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1023\/A:1012188625088","article-title":"Polar molecular surface properties predict the intestinal absorption of drugs in humans","volume":"14","author":"Palm","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.parint.2017.10.010_bb0085","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.1171085","article-title":"Apicomplexan parasites co-opt host calpains to facilitate their escape from infected cells","volume":"324","author":"Chandramohanadas","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.parint.2017.10.010_bb0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.1967.tb34871.x","article-title":"Limits of toxic and teratogenic tolerance of dimethyl sulfoxide","volume":"141","author":"Caujolle","year":"1967","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.parint.2017.10.010_bb0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1526-4610.1966.hed0603127.x","article-title":"The toxicology of dimethyl sulfoxide (DMSO)","volume":"6","author":"Jacob","year":"1966","journal-title":"Headache"},{"key":"10.1016\/j.parint.2017.10.010_bb0100","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1021\/ml400045j","article-title":"Metabolically stable tert-butyl replacement","volume":"4","author":"Barnes-Seeman","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.parint.2017.10.010_bb0105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cmdc.201402502","article-title":"Evaluation of tert-butyl Isosteres: case studies of physicochemical and pharmacokinetic properties, efficacies, and activities","volume":"10","author":"Westphal","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.parint.2017.10.010_bb0110","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1134\/S1070428007100259","article-title":"Reactions of 4-oxo-1,3-benzoxazinium perchlorates with guanidines","volume":"43","author":"Suvorova","year":"2007","journal-title":"Russ. J. Org. Chem."},{"key":"10.1016\/j.parint.2017.10.010_bb0115","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1021\/jm901241e","article-title":"Escape from flatland: increasing saturation as an approach to improving clinical success","volume":"52","author":"Lovering","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.parint.2017.10.010_bb0120","first-page":"178","article-title":"Synthesis of heterocycles through reactions of nucleophiles with acrylonitriles. Part 15. Synthesis of some new functionalized benzo[b]pyrans and indeno[1,2-b]pyrans of potential biological activity","volume":"5","author":"Abdel-Latif","year":"1995","journal-title":"J. Chem. Res."},{"key":"10.1016\/j.parint.2017.10.010_bb0125","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.bmc.2013.02.033","article-title":"Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells","volume":"21","author":"Misra","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.parint.2017.10.010_bb0130","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1248\/cpb.48.1470","article-title":"Synthesis of NG-061 and its analogs, and their biological evaluation as an enhancer of nerve growth factor","volume":"48","author":"Eguchi","year":"2000","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.parint.2017.10.010_bb0135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1021\/ml100020e","article-title":"Probing binding modes of small molecule inhibitors to the polo-box domain of human polo-like kinase 1","volume":"1","author":"Liao","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.parint.2017.10.010_bb0140","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/AAC.01203-07","article-title":"In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone","volume":"52","author":"Meneceur","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2017.10.010_bb0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.chom.2010.07.004","article-title":"Integrative genomic approaches highlight a family of parasite-specific kinases that regulate host responses","volume":"8","author":"Peixoto","year":"2010","journal-title":"Cell Host Microbe"}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576917304270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576917304270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T12:27:17Z","timestamp":1538569637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576917304270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1383576917304270"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2017.10.010","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Toxoplasma gondii inhibitor chemotypes","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2017.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}